We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Strength Training in Walking Tolerance in Intermittent Claudication Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00879697
First Posted: April 10, 2009
Last Update Posted: December 15, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Information provided by (Responsible Party):
Raphael Mendes Ritti Dias, University of Sao Paulo
Results First Submitted: January 27, 2009  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: None (Open Label);   Primary Purpose: Treatment
Conditions: Peripheral Arterial Disease
Hypertension
Diabetes
Interventions: Behavioral: Walking Training
Behavioral: Strength Training

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
From July 2005 to December 2006, three hundred patients with peripheral arterial disease, who were enrolled in a tertiary center specialized in vascular disease and were able to walk for at least 2 minutes (min) at 2 miles per hour (mph), were invited to a meeting at which explanations about this study were given.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
Seven patients did not present symptoms of claudication during the treadmill test, 5 presented electrocardiogram response suggestive of myocardial ischemia, 4 presented exercise tolerance limited by other factors than claudication, and 2 presented poorly controlled blood pressure. All these patients were not included in the study.

Reporting Groups
  Description
Strength Training Patients who performed strength training. Strength training program consisted of 8 exercises (leg press, crunches, unilateral knee extension, seated row, unilateral knee flexion, seated bench press, calf raises on leg press, and seated back extension). In each exercise, subjects performed 3 sets of 10 repetitions with a 2-minutes interval between sets and exercises.
Walking Training Patients who performed walking training. Walking training program was performed using a treadmill. In each session, patients performed fifteen 2-minutes bouts of exercise followed by a 2-minutes rest interval, as previously described. Walking speed was set in order to induce perceived exertion of 11 to 13 and claudication pain in the last 30 seconds (s) of each exercise bout.

Participant Flow:   Overall Study
    Strength Training   Walking Training
STARTED   17 [1]   17 [1] 
COMPLETED   15 [2]   15 [2] 
NOT COMPLETED   2   2 
Physician Decision                2                2 
[1] Seventeen patients achieved inclusion and exclusion criteria
[2] Two patients did not finish the trial



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Strength Training Patients who performed strength training. Strength training program consisted of 8 exercises (leg press, crunches, unilateral knee extension, seated row, unilateral knee flexion, seated bench press, calf raises on leg press, and seated back extension). In each exercise, subjects performed 3 sets of 10 repetitions with a 2-minutes interval between sets and exercises.
Walking Training Patients who performed walking training. Walking training program was performed using a treadmill. In each session, patients performed fifteen 2-minutes bouts of exercise followed by a 2-minutes rest interval, as previously described. Walking speed was set in order to induce perceived exertion of 11 to 13 and claudication pain in the last 30 s of each exercise bout.
Total Total of all reporting groups

Baseline Measures
   Strength Training   Walking Training   Total 
Overall Participants Analyzed 
[Units: Participants]
 17   17   34 
Age 
[Units: Participants]
Count of Participants
     
<=18 years      0   0.0%      0   0.0%      0   0.0% 
Between 18 and 65 years      4  23.5%      3  17.6%      7  20.6% 
>=65 years      13  76.5%      14  82.4%      27  79.4% 
Age 
[Units: Years]
Mean (Standard Deviation)
 65.7  (9.5)   64.6  (8.8)   65.1  (9.3) 
Gender 
[Units: Participants]
Count of Participants
     
Female      5  29.4%      7  41.2%      12  35.3% 
Male      12  70.6%      10  58.8%      22  64.7% 
Region of Enrollment 
[Units: Participants]
     
Brazil   17   17   34 
Total walking distance [1] 
[Units: Meter]
Mean (Standard Deviation)
 618  (282)   572  (231)   595  (244) 
[1] The maximal walking capacity of patients


  Outcome Measures

1.  Primary:   Total Walking Distance   [ Time Frame: 12 weeks ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
Our sample was composed of patients with many diseases and taking different medications.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Raphael Dias
Organization: University of São Paulo
phone: 55 81 9728 6878
e-mail: raphaelritti@gmail.com


Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Raphael Mendes Ritti Dias, University of Sao Paulo
ClinicalTrials.gov Identifier: NCT00879697     History of Changes
Other Study ID Numbers: 44444
First Submitted: January 27, 2009
First Posted: April 10, 2009
Results First Submitted: January 27, 2009
Results First Posted: April 10, 2009
Last Update Posted: December 15, 2016